SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake shares rallied significantly following strong quarterly financial results that beat expectations and included an upward revision to full-year product revenue guidance. While retail sentiment is overwhelmingly bullish, some traders are debating the stock's high valuation relative to its current profitability.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom shares experienced significant volatility following a third-quarter earnings report that featured record revenue and a massive multi-year AI semiconductor growth outlook, though a softer-than-expected fourth-quarter forecast initially pressured the stock. The community remains deeply divided, with bulls highlighting the long-term AI guidance and custom chip partnerships while skeptics question the company's reliance on a limited number of customers and long-term infrastructure financing.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology is experiencing significant downward pressure following its recent earnings report, despite beating estimates and raising guidance. Traders are debating whether the sell-off is an overreaction driven by concerns over margin compression, high customer concentration, and macro-economic factors, or if the stock is correcting from unsustainable valuation levels.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyx is trending following a significant share price decline after the Phase 3 Aspire study of its experimental Angelman syndrome drug, apazunersen, failed to meet both its primary and key secondary endpoints. While some traders are expressing concern over the clinical setback and the company's cash burn, others see a potential buying opportunity, pointing to the company's established commercial portfolio and upcoming catalysts for its remaining pipeline.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending due to the expansion of its AI partnership with HPE to scale global data center infrastructure, sparking debate about the company's valuation and cloud growth potential ahead of its upcoming earnings report. While some investors remain cautious due to debt concerns and technical volatility, many point to its massive cloud backlog and AI infrastructure demand as catalysts for a potential rebound.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as traders speculate on potential clinical data readouts and future catalysts, while monitoring price action near recent support levels ahead of upcoming scientific conferences. The community remains divided between those expecting a significant recovery driven by the company's siRNA pipeline and those expressing frustration over persistent downward price pressure and uncertainty regarding non-ambulatory patient treatment.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is receiving attention from traders focused on its role in quantum-resistant blockchain technology and potential institutional adoption, with ongoing debates between bulls optimistic about price recovery and bears skeptical of long-term value. While some community members are accumulating the token based on these technical developments and future market cycles, others remain critical of the project's price performance and foundation activities.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is surging following a strong quarterly earnings report that featured a significant upward revision to its full-year revenue outlook, driven by intense demand for AI-optimized servers. Traders are actively debating the sustainability of this momentum, with some expressing skepticism over potential market manipulation and volatility while others remain bullish on the long-term AI infrastructure growth story.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood shares are trending as investors respond to bullish price target hikes from major analysts, citing the company's growth in prediction markets and its expanded business lines. While many traders are optimistic about the stock's momentum and the growth of the Robinhood Chain, there is notable disagreement, with some users expressing frustration over perceived price suppression and manipulation, while others remain bearish on the platform's long-term outlook.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is trending following its fiscal Q1 2027 earnings report, which featured mixed results including revenue that met estimates but forward guidance that missed Wall Street expectations. While the company highlighted strong federal booking growth and a positive turnaround plan, traders remain deeply divided between those betting on a potential short squeeze due to high short interest and skeptics who view the company's financial performance and revenue outlook as weak.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Small-Cap ProMIS Neurosciences Says Lead Drug Shows Encouraging Action in Early Alzheimer's Study

ProMIS Neurosciences announced positive interim Phase 1b trial data for its Alzheimer's drug candidate PMN310, showing zero ARIA-E.read more...

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers

Gossamer Bio (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market session. The company's market cap stands at $66.4 million.
ProMIS Neurosciences (NASDAQ:PMN) shares increased byread more...

Will Declining Medical Customers Affect Cigna's Q2 Earnings?

CI's Q2 earnings are likely to face pressure from fewer insured medical customers and a higher MCR despite expected revenue growth.

Can Acute Care Strength Offset Universal Health's Rising Q2 Costs?

UHS heads into Q2 with higher admissions and revenue growth expected, but rising labor and operating costs may limit earnings upside.

Will Lower Patient Days Affect Tenet Healthcare's Q2 Earnings?

THC's Q2 performance is likely to have witnessed lower patient days, but higher revenue per admission and Ambulatory Care growth could help offset the pressure.

Will Higher Expenses Impact HCA Healthcare's Q2 Earnings?

HCA faces Q2 earnings uncertainty as rising expenses and fewer outpatient surgeries may offset admission growth.

Will Declining Membership Affect Molina Healthcare's Q2 Earnings?

MOH faces lower Marketplace revenues and membership ahead of Q2 results, while Medicaid and Medicare premium growth may offset some pressure.

Can Higher Occupancy Offset Lower Admissions in CYH's Q2 Earnings?

Community Health heads into Q2 earnings with mixed operating trends as stronger occupancy meets lower admissions and a smaller hospital portfolio.

Will Health Benefits Weakness Drag Elevance's Q2 Earnings?

ELV faces Q2 pressure as weaker Health Benefits results and higher benefit expenses may weigh on earnings ahead of its July 15 report.

Wall Street Analysts See a 230.23% Upside in Promis Neurosciences (PMN): Can the Stock Really Move This High?

The mean of analysts' price targets for Promis Neurosciences (PMN) points to a 230.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Feed

News

Sentiment

Earnings

Fundamentals

Info

PMN ProMIS Neurosciences

Fundamentals

Latest PMN News